Outlook Therapeutics Inc
F:41ON
Outlook Therapeutics Inc
F:41ON
Price:
1.537
EUR
-0.84%
Market Closed
Market Cap:
€347.3m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
O
|
Outlook Therapeutics Inc
F:41ON
|
US |
|
B
|
Baloise Holding AG
DUS:BLON
|
CH |
|
X
|
XPO Logistics Inc
F:UX2A
|
US |
|
E
|
EZCORP Inc
XBER:EZ2A
|
US |
|
G
|
GlaxoSmithKline PLC
F:GS7
|
UK |
|
Puma SE
F:PUMA
|
DE |
|
Compania de Minas Buenaventura SAA
NYSE:BVN
|
PE |
|
Vaxart Inc
OTC:VXRT
|
US |
|
Q
|
Qiagen NV
LSE:0RLT
|
NL |
|
C
|
Cardinal Health Inc
F:CLH
|
US |
|
C
|
Cameco Corp
NYSE:CCJ
|
CA |
|
H
|
Hackett Group Inc
F:AWT
|
US |
|
Gol Linhas Aereas Inteligentes SA
BOVESPA:GOLL4
|
BR |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of 41ON.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
41ON
Multiples-Based Value
Not Available
